Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4

Fig. 1

The status and prognostic value of miR-296 expression in CRC. a The expression differences of miR-296 between CRC tissues and normal tumor-adjacent tissues. n = 90. b The expression differences of miR-296 between 5 different CRC cells lines (HCT116, Caco2, HT29, SW620, SW480) and HIEC cells. *P < 0.05 versus HIEC cells. c and d Compared with those of high miR-296 level (n = 45), miR-296 low-expressing patients (n = 45) had significantly reduced overall survival and recurrence-free survival

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us